Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac and Prednisolone for CME Prevention After Cataract Surgery
NCT00469781Phase 4Completed
- Sponsor
- Center For Excellence In Eye Care
- Start
- May 2007
- Primary completion
- Sep 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisolone in cystoid macular edema (CME), sponsored by Center For Excellence In Eye Care. Primary endpoint: Cystoid Macular Edema at 11 months. Started May 2007; status: completed.
02
Drugs
prednisolone
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT00469781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469781.